Aging: silencing the PKA and AkT/PKB signaling pathways alters the antioxidant capacity of resveratrol

被引:0
作者
Filipe Nogueira Franco
Luciana de Cassia Cardoso
Bárbara Néllita Moura Silva
Glaucy Rodrigues de Araújo
Miriam Martins Chaves
机构
[1] Federal University of Minas Gerais,Biochemistry Laboratory of Aging and Correlated Diseases, Department of Biochemistry and Immunology, Biological Sciences Institute
[2] UFMG,undefined
来源
Biogerontology | 2023年 / 24卷
关键词
Resveratrol; Antioxidant; Aging; PKA; Akt/PKB; p38-MAPK;
D O I
暂无
中图分类号
学科分类号
摘要
One of the theories related to aging is the increase in oxidative stress. Given this, the objective of the study is to evaluate the cellular mechanisms responsible for the resveratrol antioxidant effect on leukocytes from donors aged between 20 and 80 years old. For this, leukocytes from donors of three age groups (20–39, 40–59 and 60–80) were isolated. Image-iT™LIVE Green Reactive Oxygen Species (ROS) Kit was used. Reactive Nitrogen Species (RNS) analysis was performed by measuring nitric oxide and peroxynitrite. The PKA, Akt/PKB and p38-MAPK were evaluated by chemiluminescence. The statistical analysis between age and treatments were performed by Pearson correlation (*p < 0.05). It was possible to observe the antioxidant effect of resveratrol in all age groups. The correlation results show loss of resveratrol effect in decreasing ROS in leukocytes from older donors. We observed an active antioxidant effect of p38-MAPK in all ages, with resveratrol acting on it. The PKA and Akt/PKB were active in leukocytes from donors aged 20–59. In cells from donors older than 60, these pathways are silenced, and an effect is also not observed in cells treated with resveratrol. Therefore, resveratrol showed antioxidant effect in all age, although it was more pronounced in leukocytes from younger. One of resveratrol’s mechanisms is due to the activation of the PKA and Akt/PKB, which were activated in younger donor cells.
引用
收藏
页码:913 / 923
页数:10
相关论文
共 130 条
[1]  
Aguilar-Alonso P(2018)Evaluation of oxidative stress in cardiomyocytes during the aging process in rats treated with resveratrol Oxid Med Cell Longev 18 1-9
[2]  
Vera-Lopez O(2017)The therapeutic potential of resveratrol: a review of clinical trials Npj Recision 35 1-9
[3]  
Brambila-Colombres E(1865)(2019) Adenosine receptors as a new target for resveratrol-mediated glioprotection Biochim Biophys Acta Mol Basis Dis 3 634-647
[4]  
Berman AY(2007)Role of inositol 1,4,5-triphosphate and p38 mitogen-activated protein kinase in reactive oxygen species generation by granulocytes in a cyclic AMP-dependent manner: an age-related phenomenon Gerontology 53 228-233
[5]  
Motechin RA(2005)Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells Biochem Biophys Res Commun 331 993-1000
[6]  
Wiesenfeld MY(2021)The role of immune cells in oxi-inflamm-aging Cells 10 2974-272
[7]  
Bobermin LD(2010)Protein kinase A signaling as an anti-aging target Ageing Res Rev 9 269-81
[8]  
Roppa RHA(2020)The therapeutic effect of resveratrol: focusing on the Nrf2 signaling pathway Biomed Pharmacother 127 110234-731
[9]  
Quincozes-Santos A(2017)The resveratrol derivatives trans-3,5-dimethoxy-4-fluoro-4’-hydroxystilbene and trans-2,4’,5-trihydroxystilbene decrease oxidative stress and prolong lifespan in caenorhabditis elegans J Pharm Pharmacol 69 73-777
[10]  
Chaves MM(2022)Aging: change in SIRT1 and enzymatic profile promotes a decrease in the antioxidant capacity of resveratrol in human leukocytes in vitro Curr Aging Sci 154 667-7